COL4A1 and breast carcinoma: Some studies have analyzed 206 surgical pathology specimens from breast cancer and adjacent tissues using immunohistochemical staining with antibodies specific to COL4A1 and evaluated the correlation between clinical results and the IHC score of COL4A1 (Wang et al., 2020).